Research Reports
Pharmacovigilance Market Size Worth $14.95 Billion By 2028
Published by Coherent Market Insights
Posted on September 20, 2021
5 min readLast updated: February 5, 2026
Global Banking & Finance Review®
Company
Published by Coherent Market Insights
Posted on September 20, 2021
5 min readLast updated: February 5, 2026
The Pharmacovigilance Market is set to reach $14.95 billion by 2028, driven by ADR incidence and key players like Accenture and Bristol-Myers Squibb.
Pharmacovigilance Market Growth & Trends
The global pharmacovigilance market size is expected to reach USD 14.95 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.5% from 2021 to 2028. The increasing incidence of Adverse Drug Reactions (ADR) is the key growth factor. ADR imposes a substantial burden on healthcare systems and is one of the prominent causes of morbidity in developed countries. According to the National Center for Biotechnology Information (NCBI), approximately 5% of total hospitalizations in Europe each year are due to ADR. Pharmacovigilance services play an integral role in this clinical trial phase by assisting manufacturers in identifying adverse effects associated with the drug.
This study provides information on the Pharmacovigilance market size, company share, sales volume, and revenue during the historical and forecast period of 2028. The research report covers key players in the industry, CAGR value, market drivers, restraints, and competitive strategies worldwide from the region.
Market reporting provides a concise overview of the segments and sub-segments including product types, applications, players and regions that provide key aspects of the market. The report focuses on COVID-19 pandemic performance impact and provides the current market and discusses in depth market conditions. The Pharmacovigilance market report has been able to proceed with a thorough study of market dynamics,changing consumer behavior,and the flow of global supply chains affected by the Pharmacovigilance market. These important insights of reporting goals present strong guidance for customers to get information about their business decisions from their investment market to assess the factors that are likely to affect current and future market conditions.
https://www.stratagemmarketinsights.com/sample/42243
Leading players of Pharmacovigilance Market including:
Accenture Plc, Bristol-Myers Squibb, Clinquest Group B.V., Cognizant Technology Solutions, Covance Inc., GlaxoSmithKline, ICON, Plc, iGATE Corporation, Arriello, iMEDGlobal Corporation, Diamond Pharma Services, Infosys, Ergomed plc, inVentiv Health Inc., APCER Life Sciences, ArisGlobal, Johnson and Johnson.
The Pharmacovigilance market is divided into a number of segments. The research based on the Pharmacovigilance industry offers a thorough analysis of each of these segments and sub-segments that they are divided into. some of the major segments included in the market research areas type, applications, etc.
Pharmacovigilance Market – Segmentation
By Type:
Spontaneous Reporting, Intensified ADR Reporting, Targeted Reporting, Cohort Event Monitoring, EHR Monitoring.
By Applications:
In-House , Contract Outsourcing.
The final report will add the analysis of the Impact of Covid-19 in this report Pharmacovigilance Market.
Adapting to the recent novel COVID-19 pandemic, the impact of the COVID-19 pandemic on the global Pharmacovigilance Market is included in the present report. The influence of the novel coronavirus pandemic on the growth of the Pharmacovigilance Market is analyzed and depicted in the report.
Geographic Segment Covered in the Report:
The Pharmacovigilance report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country and sub-region during the estimated period.
https://www.stratagemmarketinsights.com/discount/42243
The Pharmacovigilance report provides insights on the following pointers:
Research Methodology
The report has its roots definitely set in thorough strategies provided by the proficient data analysts. The research methodology involves the collection of information by analysts only to have them studied and filtered thoroughly in an attempt to provide significant predictions about the market over the review period. The research process further includes interviews with Pharmacovigilance market influencers, which makes the primary research relevant and practical. The secondary method gives a direct peek into the demand and supply connection. The market methodologies adopted in the report offer precise data analysis and provides a Pharmacovigilance market.
You Can Buy Report Here @ https://www.stratagemmarketinsights.com/cart/42243
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
-MN
The post Pharmacovigilance Market Size Worth $14.95 Billion By 2028 appeared first on Gatorledger.
The main topic is the growth and trends of the Pharmacovigilance Market, projected to reach $14.95 billion by 2028.
How does ADR impact the Pharmacovigilance Market? ADR significantly drives market growth due to its burden on healthcare systems.
Which companies are key players? Companies like Accenture, Bristol-Myers Squibb, and GlaxoSmithKline are major players.
Explore more articles in the Research Reports category
